methylprednisolone acetate has been researched along with Prediabetic State in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Prediabetic State: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Talat, L | 1 |
| Tomkins-Netzer, O | 1 |
| Taylor, SR | 1 |
| Din, NM | 1 |
| Bar, A | 1 |
| Isa, H | 1 |
| Lightman, S | 1 |
1 other study available for methylprednisolone acetate and Prediabetic State
| Article | Year |
|---|---|
The influence of diabetes mellitus on the management and visual outcome of patients with uveitis.
Topics: Anti-Inflammatory Agents; Cataract; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Methylpredni | 2014 |